Octreotide Teva (Octreotide Acetate)

Octreotide acetate, the active ingredient in Octreotide Teva, is a somatostatin analog presented as a strength/form for injection use. It treats hormone‑secreting tumors and related endocrine disorders in adults and children. GNH USA supplies Octreotide Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Octreotide Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Octreotide Teva is a somatostatin analog that modulates hormone secretion in several endocrine conditions. - Acromegaly: reduces excess growth hormone and alleviates associated symptoms. - Neuroendocrine tumors: controls hormone‑related flushing and diarrhea. - Carcinoid syndrome: diminishes flushing, wheezing and gastrointestinal secretions. - Preventive management of postoperative pancreatic fistula: lowers fistula incidence after pancreatic surgery. - Control of severe hypoglycemia: stabilizes blood glucose in refractory cases.

Both             …  …  ... ...  … … …  …  … …  ...  … ....